Rothwell, S.* ; Cooper, R.G.* ; Lundberg, I.E.* ; Miller, F.W.* ; Gregersen, P.K.* ; Bowes, J.* ; Vencovsky, J.* ; Danko, K.* ; Limaye, V.* ; Selva-O'Callaghan, A.* ; Hanna, M.G.* ; Machado, P.M.* ; Pachman, L.M.* ; Reed, A.M.* ; Rider, L.G.* ; Cobb, J.* ; Platt, H.* ; Molberg, O.* ; Benveniste, O.* ; Mathiesen, P.* ; Radstake, T.* ; Doria, A.* ; de Bleecker, J.* ; de Paepe, B.* ; Maurer, B.* ; Ollier, W.E.* ; Padyukov, L.* ; O'Hanlon, T.P.* ; Lee, A.* ; Amos, C.I.* ; Gieger, C. ; Meitinger, T. ; Winkelmann, J. ; Wedderburn, L.R.* ; Chinoy, H.* ; Lamb, J.A.*
     
 
    
        
Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups.
    
    
        
    
    
        
        Ann. Rheum. Dis. 75, 1558-1566 (2016)
    
    
    
		
		
			
				OBJECTIVES: The idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of rare autoimmune diseases characterised by muscle weakness and extramuscular manifestations such as skin rashes and interstitial lung disease. We genotyped 2566 IIM cases of Caucasian descent using the Immunochip; a custom array covering 186 established autoimmune susceptibility loci. The cohort was predominantly comprised of patients with dermatomyositis (DM, n=879), juvenile DM (JDM, n=481), polymyositis (PM, n=931) and inclusion body myositis (n=252) collected from 14 countries through the Myositis Genetics Consortium. RESULTS: The human leucocyte antigen (HLA) and PTPN22 regions reached genome-wide significance (p<5×10(-8)). Nine regions were associated at a significance level of p<2.25×10(-5), including UBE2L3, CD28 and TRAF6, with evidence of independent effects within STAT4. Analysis of clinical subgroups revealed distinct differences between PM, and DM and JDM. PTPN22 was associated at genome-wide significance with PM, but not DM and JDM, suggesting this effect is driven by PM. Additional suggestive associations including IL18R1 and RGS1 in PM and GSDMB in DM were identified. HLA imputation confirmed that alleles HLA-DRB1*03:01 and HLA-B*08:01 of the 8.1 ancestral haplotype (8.1AH) are most strongly associated with IIM, and provides evidence that amino acids within the HLA, such as HLA-DQB1 position 57 in DM, may explain part of the risk in this locus. Associations with alleles outside the 8.1AH reveal differences between PM, DM and JDM. CONCLUSIONS: This work represents the largest IIM genetic study to date, reveals new insights into the genetic architecture of these rare diseases and suggests different predominating pathophysiology in different clinical subgroups.
			
			
				
			
		 
		
			
				
					
					Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Scopus
Cited By
					
					Altmetric
					
				 
				
			 
		 
		
     
    
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
    
        Typ der Hochschulschrift
        
    
 
    
        Herausgeber
        
    
    
        Schlagwörter
        Dermatomyositis ; Gene Polymorphism ; Polymyositis; Genome-wide Association; Inclusion-body Myositis; Susceptibility Loci; Tyrosine-phosphatase; Disease; Variants; Dermatomyositis; Population; Polymyositis; Expression
    
 
    
        Keywords plus
        
    
 
    
    
        Sprache
        
    
 
    
        Veröffentlichungsjahr
        2016
    
 
    
        Prepublished im Jahr 
        2015
    
 
    
        HGF-Berichtsjahr
        2015
    
 
    
    
        ISSN (print) / ISBN
        0003-4967
    
 
    
        e-ISSN
        1468-2060
    
 
    
        ISBN
        
    
 
    
        Bandtitel
        
    
 
    
        Konferenztitel
        
    
 
	
        Konferzenzdatum
        
    
     
	
        Konferenzort
        
    
 
	
        Konferenzband
        
    
 
     
		
    
        Quellenangaben
        
	    Band: 75,  
	    Heft: 8,  
	    Seiten: 1558-1566 
	    Artikelnummer: ,  
	    Supplement: ,  
	
    
 
  
        
            Reihe
            
        
 
        
            Verlag
            BMJ Publishing Group
        
 
        
            Verlagsort
            London
        
 
	
        
            Tag d. mündl. Prüfung
            0000-00-00
        
 
        
            Betreuer
            
        
 
        
            Gutachter
            
        
 
        
            Prüfer
            
        
 
        
            Topic
            
        
 
	
        
            Hochschule
            
        
 
        
            Hochschulort
            
        
 
        
            Fakultät
            
        
 
    
        
            Veröffentlichungsdatum
            0000-00-00
        
 
         
        
            Anmeldedatum
            0000-00-00
        
 
        
            Anmelder/Inhaber
            
        
 
        
            weitere Inhaber
            
        
 
        
            Anmeldeland
            
        
 
        
            Priorität
            
        
 
    
        Begutachtungsstatus
        Peer reviewed
    
 
     
    
        POF Topic(s)
        30202 - Environmental Health
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
30205 - Bioengineering and Digital Health
    
 
    
        Forschungsfeld(er)
        Genetics and Epidemiology
    
 
    
        PSP-Element(e)
        G-504091-004
G-500700-001
G-503200-001
G-504100-001
    
 
    
        Förderungen
        
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2015-09-14